The constitutive activation of STAT3 and the NF-kappa B signaling pathway led to the up-regulation of Notch pathway promoter expression in human glioma CSC, which determined a new therapeutic target for glioma therapy [44]. This evidence concerns the gene STAT3 and glioma.